Overview

• The new hepatitis B validation in October 2025 builds on Maldives’ 2019 WHO validations for HIV and syphilis, confirming the world’s first triple elimination status.
• National data show no babies were born with HIV or syphilis in 2022 and 2023, and a 2023 survey found zero hepatitis B among first-grade children.
• More than 95% of pregnant women receive antenatal care with nearly universal screening for HIV, syphilis and hepatitis B, supported by strong birth‑dose and full-course hepatitis B vaccination.
• Universal health coverage guarantees free antenatal services, diagnostics and vaccines for residents, including migrants, backed by partnerships across government, private providers, civil society and WHO, and health spending reported above 10% of GDP.
• Maldives and WHO plan to sustain elimination through digital health information systems, targeted outreach to migrants and key populations, stronger private-sector reporting and improved laboratory quality, as WHO notes substantial ongoing burdens across the South‑East Asia Region.